Skip to content
Join KHI
  • Who We Are
    • Why We Exist
    • Strategic Goals
    • Our Impact
    • Governance
    • FAQs
    • Member Organizations
    • Our Team
    • Contact Us
  • Projects
    • Current Projects
    • Our Portfolio
  • Get Involved
    • Join KHI
    • Join a Project Workgroup
    • Register for Event
    • Submit a Project
  • Find Resources
    • Publications
    • Events
    • Multimedia
  • Who We Are
    • Why We Exist
    • Strategic Goals
    • Our Impact
    • Governance
    • FAQs
    • Member Organizations
    • Our Team
    • Contact Us
  • Projects
    • Current Projects
    • Our Portfolio
  • Get Involved
    • Join KHI
    • Join a Project Workgroup
    • Register for Event
    • Submit a Project
  • Find Resources
    • Publications
    • Events
    • Multimedia
Tag: Publication

Roadmap For Advancing Awareness, Genetic Testing, And Clinical Studies Of Apol1 Kidney Disease

Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access

Fostering Innovation in Symptom Management among Hemodialysis Patients Paths Forward for Insomnia, Muscle Cramps, and Fatigue

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes

Recommended Clinical Trial End Points for Dialysis Catheters

FDA Regulatory Perspectives for Studies on Hemodialysis Vascular Access

Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions

Including People with Kidney Diseases in COVID-19 Trials: Opportunity for Participation in Vaccine Trials, September 14, 2020

Making the Case for Change: Including People with Kidney Diseases in COVID-19 Trials, May 14, 2020

Xenotransplantation and the Role of the Patient Voice

Page1 Page2 Page3 Page4 Page5

A Public-Private Partnership

KHI was founded in 2012 as a partnership between ASN and the FDA

Conflict of Interest | Privacy Policy

Contact Us

  • 202-640-4660
  • khi@asn-online.org